Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

TD Cowen downgraded Merck (MRK) to Hold from Buy with a price target of $100, down from $121. The firm says its Buy thesis “broke down” with Gardasil’s challenges in China. It is ...

Merck KGaA (MKGAY) confirms “advanced discussions” with Springworks Therapeutics (SWTX) regarding a potential acquisition. “Merck also confirms that no legally binding agreement has been ...

(This Feb. 10 story has been refiled to say 'LOEs (loss of exclusivity),' not 'LOEs (levels of evidence),' in paragraph 13) ...

Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...

Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

U.S. President Donald Trump, right, and Justin Trudeau, Canada's prime minister, arrive to a news conference in the East Room of the White House in Washington, D.C., U.S., on Monday, Feb. 13, 2017 ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

SEC Filings provided by EDGAR Online, Inc.

(TTU.edu) Chicago | Reuters –– Merck and Co. is funding the testing of lower dosages of its controversial cattle growth drug Zilmax, in a move livestock experts say is crucial if the company is to ...

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.